Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Shoulder Innovations, Inc.NYSE: SI
Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026
Deferred revenue remains negative
Q1 FY2026 deferred revenue was $0, compared with $0 a year earlier.
Context
- Deferred revenue amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Deferred revenue increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Deferred Revenue vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 deferred revenue of $0 is the 5th highest of the 11 companies compared; the peer median is $0.
- Deferred revenue amounts to 0.0% of total assets for SI, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $29.08M | -28.8% | — | 12.3% | |
| Mar 2026 | $12.64M | -4.2% | +16.8% | 5.1% | |
| Mar 2026 | $5.09M | -20.6% | -14.7% | 1.8% | |
| Dec 2025 | $534K | +281.4% | +43.2% | 0.3% | |
| Mar 2026 | $0 | — | — | 0.0% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | +86.3% | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SI) | $0 | -20.6% | +30.0% | 0.0% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.